Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Upcoming Clinical Trials

The following clinical trials are coming soon:

  • A Phase 1/2a, Open-Label, Parallel, Two-Arm Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BAX69 in Subjects with Refractory Ovarian Cancer with Malignant Ascites, sponsor Baxter
  • Does physician education influence side effect management and does it increase time on treatment in the absence of progression? A phase 4 open-label trial with regorafenib in metastatic colorectal cancer, sponsor Bayer
  • Biomarker Study: MTG-022 Tissue And Bodily Fluids Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients, sponsor The MT Group, Inc
  • Assessing the Association between Patients’ Perceptions of Success with Post-Operative Pain Management and Overall Experience with Care, sponsor The Medicines Company
  Holy Cross Hospital
  Holy Cross Germantown Hospital

© 2016  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000